Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: Role of the cAMP pathway

Journal of Neuroendocrinology

Volumn 10, Issue 3, 1998, Pages 199-206

  Vargas, Miguel Angel ^a   Bourdais, Julie ^a   Sanchez, Sonia ^a   Uriostegui, Bernardo ^a   Moreno, Eloy ^a   Joseph Bravo, Patricia ^a   Charli, Jean Louis ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

Degradation; Dopamine; Lactotroph; Pyroglutamyl peptidase II; TRH

Indexed keywords

5 OXOPROLYL PEPTIDASE; BROMOCRIPTINE; BUCLADESINE; CHOLERA TOXIN; CYCLIC AMP; FORSKOLIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; ISOBUTYLMETHYLXANTHINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROLACTIN; PROTEIN KINASE C; SOMATOSTATIN;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; SIGNAL TRANSDUCTION;

AMINOPEPTIDASES; ANIMALS; CELLS, CULTURED; CYCLIC AMP; FEMALE; HYPOTHALAMUS; PITUITARY GLAND, ANTERIOR; PROTEIN KINASE C; PYRROLIDONECARBOXYLIC ACID; RATS; RNA, MESSENGER;

EID: 0031885854     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1998.00186.x     Document Type: Article

References (43)

1. Lamberts SWJ, MacLeod RM. Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 1990; 70: 279-318.
2. Martinez de la Escalera G, Weiner RI. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion. Endoc Rev 1992; 13: 241-255.
3. Gershengorn MC, Osman R. Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiol Rev 1996; 76: 175-191.
4. De Lean A, Ferland L, Drouin J, Kelly PA, Labrie F. Modulation of pituitary thyrotropin releasing hormone receptor levels by estrogens and thyroid hormones. Endocrinology 1977; 100: 1496-1504.
5. Tashjian Jr AH, Osborne R, Maina D, Knaian A. Hydrocortisone increases the number of receptors for thyrotropin-releasing hormone on pituitary cells in culture. Biochem Biophys Res Commun 1977; 79: 333-340.
6. Garat B, Miranda J, Charli JL, Joseph-Bravo P. Presence of a membrane bound pyroglutamyl aminopeptidase degrading thyrotropin releasing hormone in rat brain. Neuropeptides 1985; 6: 27-40.
7. O'Connor B, O'Cuinn G. Localization of a narrow specificity thyroliberin hydrolysing pyroglutamate aminopeptidase in synaptosomal membranes of guinea-pig brain. Eur J Biochem 1984; 144: 271-278.
8. Charli JL, Cruz C, Vargas MA, Joseph-Bravo P. The narrow specificity pyroglutamate amino peptidase degrading TRH in rat brain is an ectoenzyme. Neurochem Int 1988; 13: 237-242.
9. Wilk S. Neuropeptide-specific peptidases: does brain contain a specific TRH-degrading enzyme? Life Sci 1986; 39: 1487-1492.
10. Bauer K, Carmeliet P, Schulz M, Baes M, Denef C. Regulation and cellular localization of the membrane-bound thyrotropin-releasing hormone-degrading enzyme in primary cultures of neuronal, glial and adenohypophyseal cells. Endocrinology 1990; 127: 1224-1233.
11. Vargas MA, Herrera J, Uribe RM, Charli JL, Joseph-Bravo P. Ontogenesis of pyroglutamyl peptidase II activity in rat brain, adenohypophysis and pancreas. Der Brain Res 1992; 66: 251-256.
12. Uribe RM, Joseph-Bravo P, Pasten J, Ponce G, Méndez M. Covarrubias L, Charli JL. Some events of thyrotropin-releasing hormone metabolism are regulated in lactating and cycling rats. Neuroendocrinology 1991; 54: 493-498.
13. Bauer K. Degradation and biological inaetivation of thyrotropin releasing hormone (TRH): regulation of the membrane-bound TRH-degrading enzyme from rat anterior pituitary by estrogens and thyroid hormones. Biochimie 1988; 70: 69 74.
14. Ponce G, Charli JL, Pasten JA, Aceves C, Joseph-Bravo P. Tissuespecific regulation of pyroglutamate aminopeptidase II activity by thyroid hormones. Neuroendocrinology 1988; 48: 211-213.
15. Vargas MA, Joseph-Bravo P, Charli JL. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells, Neuroendocrinology 1994; 60: 323 330.
16. Martin TFJ, Kowalchyk JA. Evidence for the role of calcium and diacylglycerol as dual second messengers in thyrotropin-releasing hormone action: involvement of diacylglycerol. Endocrinology 1984; 115: 1517 1526.
17. 2+. Endocrinology 1984; 115: 1527 1536.
18. Murdoch GH, Waterman M, Evans RM, Rosenfeld MG. Molecular mechanisms of phorbol ester, thyrotropin-releasing hormone, and growth factor stimulation of prolactin gene transcription. J Biol Chem 1985; 260: 11852-11851.
19. Ramsdell JS, Tashjian Jr AH. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity. Endocrinology 1985; 117: 2050-2060.
20. 3 cells. J Biol Chem 1986; 261: 2684-2689.
21. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB. The somatostatin receptor family. Life Sci 1995; 57: 1249 1265.
22. Reisine T, Bell GI. Molecular biology of somatostatin receptor. Endocrine Rev 1995; 16: 427-442.
23. Tang F. Endocrine control of hypothalamic and pituitary met-enkephalin and beta-endorphin contents. Neuroendocrinology 1991; 53 (S1): 68 76.
24. Rawlings SR, Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endoc Rev 1996; 17: 4-29.
25. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2 (p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265: 5267 5272.
26. Ship MA, Stefano GB, D'Adamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer B, Reinherz EL. Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 1990; 347: 394-396.
27. Ray KP, Wallis M. Regulation of growth hormone secretion and cyclic AMP metabolism in ovine pituitary cells: interactions involved in activation induced by growth hormone-releasing hormone and phorbol esters. Mol Cell Endoc 1988; 58: 243 252.
28. Ogiwara T, Chik CL, Ho AK. Tyrosine kinase inhibitors enhance GHRH-stimulated cAMP accumulation and GH release in rat anterior pituitary cells. J Endoc 1997; 152: 193 9.
29. + channels is independent of adenylate cyclase activation. Science 1988; 240: 1652-1655.
30. Park TJ, Jim KT. Cyclic AMP-independent inhibition of voltage-sensitive calcium channels by forskolin in PC12 cells. J Neurochem 1996; 66: 83-88.
31. 2 dopaminergic receptors: normal and abnormal transduction mechanisms. Hormone Res 1992; 38: 78 83.
32. Lledo P, Legendre P, Israel JM, Vincent JD. Dopamine inhibits two characterized voltage-dependent calcium currents in identidied rat lactotroph cells. Endocrinology 1990; 127: 990-1001.
33. Lledo P, Legendre P, Zhang J, Israel JM, Vincent JD. Effects of dopamine on voltage-dependent ptassium currents in identified rat lactotroph cells. Neuroendocrinology 1990; 52: 545 555.
34. 2 dopamine receptor activation of potassium channels in identified rat laciotrophs: whole-cell and single-channel recording. J Neurosci 1991; 11: 3727-3737.
35. Israel JM, Kirk C, Vincent JD. Electrophysiological responses to dopamine of rat hypophyseal cells in lactotroph-enriched primary cultures. J Physiol Lond 1987; 390: 1-22.
36. Schomburg L, Bauer K. Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme. Endocrinology 1995; 136: 3480-3485.
37. Yoshimoto T, Walter R. Post-proline dipeptidyl aminopeptidase (dipeptidyl aminopeptidase IV) from lamb kidney. Biochim Biophys Acta 1977; 485: 391-394.
38. Friedman TC, Wilk S. Delineation of a particulate thyrotropin-releasing hormone degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase. J Neurochem 1986; 46: 1231-1239.
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
40. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156 159.
41. Uribe RM, Pérez-Martinez L, Covarrubias ML, Gómez OB, Covarrubias L, Charli JL, Joseph-Bravo P. Phorbol ester or cAMP enhance thyrotropin releasing hormone mRNA in primary cultures of hypothalamic cells. Neurosci Lett 1995; 201: 41-14.
42. Schauder B, Schomburg L, Köhrle J, Bauer K. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin releasing hormone. Prac Natl Acad Sci USA 1994; 91: 9334-9538.
43. Tso JH, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985: 13: 2485-2502.